Combination treatment of pembrolizumab with DC-CIK cell therapy for advanced hepatocellular carcinoma: A case report

BACKGROUND: Recently, immunotherapy has emerged as a promising method for advanced HCC treatment. There are several clinical trials and meta-analyses of immune checkpoint inhibitors and immune cell therapy, but clinical evidence on the combination of these two therapies is lacking. CASE DESCRIPTION:...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Shao M., Jeng, Long-Bin, Shyu, Woei-Cherng, Chen, Hung-Yao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: China Medical University 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627209/
https://www.ncbi.nlm.nih.gov/pubmed/37937058
http://dx.doi.org/10.37796/2211-8039.1414

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627209/
https://www.ncbi.nlm.nih.gov/pubmed/37937058
http://dx.doi.org/10.37796/2211-8039.1414

Ejemplares similares